Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti, Ina Oehme, Olaf Witt, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 7, pp. 481-492
Open Access | Times Cited: 240

Showing 1-25 of 240 citing articles:

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho, Alex H. Y. Chan, A. Ganesan
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12460-12484
Open Access | Times Cited: 566
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Andrey D. Bondarev, Misty M. Attwood, Jörgen Jönsson, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 12, pp. 4577-4597
Open Access | Times Cited: 279
Zinc binding groups for histone deacetylase inhibitors
Lei Zhang, Jian Zhang, Qixiao Jiang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 714-721
Open Access | Times Cited: 194
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective
Vishal Kumar, Satyabrata Kundu, Arti Singh, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 1, pp. 158-178
Open Access | Times Cited: 118
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
Weiqin Yang, Yu Feng, Jingying Zhou, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 588
Closed Access | Times Cited: 107
Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih, Islam M. Abdel-Rahman, Nawal El‐Koussi, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 966-1010
Open Access | Times Cited: 2
Targeting Class I Histone Deacetylases in a “Complex” Environment
Christopher J. Millard, Peter J. Watson, Louise Fairall, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 4, pp. 363-377
Closed Access | Times Cited: 160
Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy
Tingting Liu, Yichao Wan, Yuliang Xiao, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 17, pp. 8977-9002
Closed Access | Times Cited: 130
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis
Tino Heimburg, Alokta Chakrabarti, Julien Lancelot, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 6, pp. 2423-2435
Open Access | Times Cited: 117
Quercetin modifies 5′CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells
Madhumitha Kedhari Sundaram, Arif Hussain, Shafiul Haque, et al.
Journal of Cellular Biochemistry (2019) Vol. 120, Iss. 10, pp. 18357-18369
Closed Access | Times Cited: 111
Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
Debarati Banik, Sara Moufarrij, Alejandro Villagra
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2241-2241
Open Access | Times Cited: 107
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants
Martin Marek, T.B. Shaik, Tino Heimburg, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 10000-10016
Open Access | Times Cited: 103
Design, Synthesis, and Pharmacological Evaluation of NovelN-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors
Daniel A. Rodrigues, Guilherme Álvaro Ferreira‐Silva, Ana Carolina S. Ferreira, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 655-670
Closed Access | Times Cited: 99
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Suvankar Banerjee, Nilanjan Adhikari, Sk. Abdul Amin, et al.
European Journal of Medicinal Chemistry (2018) Vol. 164, pp. 214-240
Closed Access | Times Cited: 97
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Alokta Chakrabarti, Jelena Melesina, Fiona R. Kolbinger, et al.
Future Medicinal Chemistry (2016) Vol. 8, Iss. 13, pp. 1609-1634
Open Access | Times Cited: 95
A Genetically Encoded, Phage‐Displayed Cyclic‐Peptide Library
Xiaoshan Shayna Wang, Peng‐Hsun Chase Chen, J. Trae Hampton, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 44, pp. 15904-15909
Open Access | Times Cited: 91
Targeting post-translational histone modifying enzymes in glioblastoma
Elena Kunadis, Eleftheria Lakiotaki, Penelope Korkolopoulou, et al.
Pharmacology & Therapeutics (2020) Vol. 220, pp. 107721-107721
Closed Access | Times Cited: 83
Pathological Role of HDAC8: Cancer and Beyond
Ji Yoon Kim, Hayoung Cho, Jung Yoo, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3161-3161
Open Access | Times Cited: 47
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Jiranan Chotitumnavee, Yasunobu Yamashita, Yukari Takahashi, et al.
Chemical Communications (2022) Vol. 58, Iss. 29, pp. 4635-4638
Closed Access | Times Cited: 40
The role of altered protein acetylation in neurodegenerative disease
Fariha Kabir, Rachel A.K. Atkinson, Anthony L. Cook, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 37
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 14
Sex-specific Associations of Gene Expression with Alzheimer's Disease Neuropathology and Ante-mortem Cognitive Performance
Mabel Seto, Michelle Clifton, Manuel J. Gómez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity
Tino Heimburg, Fiona R. Kolbinger, Patrik Zeyen, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 24, pp. 10188-10204
Closed Access | Times Cited: 82
HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy
Michael F. Emmons, Fernanda Faião‐Flores, Ritin Sharma, et al.
Cancer Research (2019) Vol. 79, Iss. 11, pp. 2947-2961
Open Access | Times Cited: 68
Anaplasma phagocytophilumincreases the levels of histone modifying enzymes to inhibit cell apoptosis and facilitate pathogen infection in the tick vectorIxodes scapularis
Alejandro Cabezas‐Cruz, Pilar Alberdi, Nieves Ayllón, et al.
Epigenetics (2016) Vol. 11, Iss. 4, pp. 303-319
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top